Could intrathecally administered methotrexate be a viable treatment option for your patients with progressive forms of multiple sclerosis?
Saud A. Sadiq, MD
Advertisement
Articles by Saud A. Sadiq, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
Zasocitinib Tops Deucravacitinib for Skin Clearance in Phase 3 Psoriasis Trial
2
FDA Clears Wave Neuroscience MeRT System for PTSD
3
AD109 Reduces OSA Severity in Phase 3 Trial of CPAP-Intolerant Adults
4
7 Late-Breaking Clinical Trials to Watch For at SLEEP 2026
5